AMR NEWS: Your Global Source for the Latest AMR Insights and Publications!

Search for:

Home » _News » Smart Innovations » Page 11

AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.

12 October 2021

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan

Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study

Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning

AMR in Orthopedics – Benefits of topical treatment and latest advances

WHO 2021 data call is now open for both antibacterials and antifungals in the preclinical development pipeline

Chip Detects Antibiotics in Exhaled Breath

Scientists, biotechs look to unlock the potential of phage therapy

Bioinformatics approaches to the study of antimicrobial resistance

BactiVac and AMR Insights to join forces

30 September 2021

Antimicrobial Peptides—or How Our Ancestors Learned to Control the Microbiome

27 September 2021

Accelerating antibiotic discovery through artificial intelligence

27 September 2021

Will AI save us from antibiotic resistance?

8 September 2021

Antibacterial Medicinal Chemistry – What Can We Design For?

3 September 2021

Open call for peer reviewers Policy Paper on the use of Data Technologies to combat AMR

3 September 2021

Interim analysis data available from AMR survey

2 September 2021

CHEMISTRY CENTER FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA (CC4CARB)

Estimating Global Patient Needs and Market Potential for Priority Health Technologies Addressing Antimicrobial Resistance

Towards the sustainable discovery and development of new antibiotics

LSHTM launches new centre of innovation to tackle antimicrobial resistance and tuberculosis

JPIAMR-VRI Digital Platform

Microfluidic filter device coupled mass spectrometry for rapid bacterial antimicrobial resistance analysis

AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

Integrating programmable DNAzymes with electrical readout for rapid and culture-free bacterial detection using a handheld platform

Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics

Brexit will not end scientific collaboration between the UK and EU

The AMR Action Fund is combating antimicrobial resistance, but much more action is needed

Congress needs to fix the broken market for antibiotic development

New Technique Enables Quick Identification of Potential Drugs to Fight Antibiotic-Resistant Bacteria

Qpex Biopharma Initiates Phase 1 Study of QPX9003 Targeting Antibiotic-Resistant Pathogens

New Web Tool Fights Antibacterial Resistance

A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile

Predicting Antimicrobial Resistance Using Partial Genome Alignments

Renewed Introduction of the PASTEUR Act Returns AMR to National Agenda

Interdisciplinary GW4 AMR Alliance is to become the UK’s leading ‘One Health’ AMR research consortium, recognised globally

Hope amid challenging times for antibiotic developers

Biotechs are saving the world from superbugs. Can they also save themselves?

Experimental vaccine forces bacteria down an evolutionary dead end

EPSRC funding announced to tackle resistance to antibiotics

Urgent Action Needed to Spur Antibiotic Innovation

GARDP Receives Funding From the Government of Japan as Part of Its Ongoing Contribution To Fight Against Drug-Resistant Infections

CARB-X IS FUNDING ACCELERATE DIAGNOSTICS TO DEVELOP A RAPID OPTICAL IMAGING DIAGNOSTIC FOR SEPSIS AND SERIOUS ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS

Trained viruses prove more effective at fighting antibiotic resistance

Novel tool to visualize antibiotic resistance

The plot thickens: data visualization in antimicrobial resistance research

Adaptive Phage Therapeutics Initiates Phase 1/2 Trial of PhageBank™ in Urinary Tract Infections

SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Nanotherapeutics Hub joins iiCON to help strengthen UK’s infectious disease products pipeline

CARB-X IS FUNDING SWISS PHARMA COMPANY BIOVERSYS TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT INFECTIONS CAUSED BY MULTIDRUG-RESISTANT ESKAPE PATHOGENS

Fight Against Antibiotic-Resistant Bacteria Has a Glowing New Weapon

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed